| 
      
        |  | Associated Network Functions | Score | Focus Molecules | Molecules in Network |  
        | Proteins common to both pools | Cell-To-Cell    Signaling and Interaction, Hematological System Development and Function | 47 | 29 | 26s Proteasome, A2M, APOB, APOE, APOH, C3, C5, CFB, F2, F10, F11, HABP2, ITLN1, LCN2, LTF,MIF, MPO, MUC5AC/MUC5B, PLG,PON1, PRDX1, PROC, PROS1, RBP4, SERPINA1, SERPINC1, SERPING1, SMPD2,TF |  
        | Cellular    Assembly and Organization, Cellular Function and Maintenance, Cellular    Movement | 40 | 28 | ACTB, Actin, ACTN1, APOD, C2, C9, CAP1, CD55, CD59, CLU, EN01, Factin, FBLN1, FLNA, FN1, GAPDH, GSN, HBG1, HSP90AB1, Iti, ITIH1, ITIH2, LCP1,    MDK, MUC4, NPC2, PGK1, VTN, YWHAZ |  
        | Cancer | 23 | 18 | AHSG, ALB, APOA2, C1R, C1S, C4BPA, CD163, CFHR1,    Fibrinogen, FOLR1, HPX, ITIH4, KLKB1, KNG1, MUC4, ORM1, SERPINA1, SERPINA3 |  
        | Cell-To-Cell    Signaling and Interaction, Hematological System Development and Function | 18 | 15 | AMBP, C1QA, C8A, CD163, CP, HRG, IGHA1, IGHA2, IGHG2, PGD, PGLYRP2, PIGR, PRDX2, TAP2, TUBB4B |  
        | Proteins detected only in the benign pool | Cellular    Movement, Cell-To-Cell Signaling and Interaction, Tissue Development | 43 | 25 | ANXA1, C5, CD55, CD59, CDH13, CLU, DMBT1, DUOX2, EPS8L2, EZR, FBLN1, GNAI3, GNB2, GSN, MSN, MUC1, MUC4, RAC1, RAP1A, RAP1B, RDX, SDCBP, SPARC,SPP1, THY1 |  
        | Cell Death and    Survival | 15 | 12 | ACE,A NXA4, BAIAP2, C7, CHI3L1, FBLN2, GNA13, IFITM2,    PDCD6IP, PROM1, SPARCL1, UBA52 |  
        | Carbohydrate    Metabolism, Lipid Metabolism, Small Molecule Biochemistry | 14 | 12 | APOA2, C4B    (includes others), CFB, COL1A2, CST3, GNAQ, HPX,LDL, MUC16, PIGR, QSOX1, TM4SF1 |  
        | Cellular    Movement | 14 | 11 | ADAM9, ANXA2, CTSB, FN1,    KRT19, OLFM4, S100A6, SLC9A3R1, SMPDL3B, SNX18, TTR |  
        | Proteins detected only in the malignant pool | Protein    Synthesis, Molecular Transport, Protein Trafficking | 43 | 30 | ACTB, Actin,ACTR3, CAP1, ENO1, ERCC6, FASN, FGG, FLNA, GAPDH, GNB2L1, HNRNPA1, HNRNPK, HNRNPU, ILF3, KPNB1, MAP4, NCL, NPM1, NUMA1, NUTF2, OTUB1, PKM, PLEC, RPS8, RPS14, SSB, TAGLN2, XPO1, YBX1 |  
        | Cell-To-Cell    Signaling and Interaction, Tissue Development, Cellular Movement | 41 | 29 | ACTN4, ARHGDIA, C5, CALR, CAT, CDH5, CORO1A, EEF1A1, F10, Fibrinogen, FLNB, FN1, GP1BA, GPI, KNG1, LBP, LTF, MBL2, MCAM, MMP9, MPO, NAMPT, PROC, PSMB9, RHOA, RPS3A, SPTAN1, VCL, VCP |  
        | Post-Translational    Modification, Protein Folding | 26 | 21 | ANXA5, CAPZA1, CD44, CRP, CTTN, CYCS,    FActin, HNRNPD, Hsp27, Hsp70, Hsp90, HSP90AB1, HSPA5, HSPA8, HSPB1,Igm, LCP1, LDL,    NONO, PPIA, RPL6, SOD1, TIMP1,TLN1,TUBA1A, YWHAQ |  
        | Cell-To-Cell    Signaling and Interaction, Hematological System Development and Function, Immune    Cell Trafficking | 16 | 16 | APOA4, APOM, ARPC2,    DEFA1 (includes others), EEF1A2, GPLD1, HNRNPAB, Iti,ITIH1, ITIH2, LAP3,    PSMB8, PSMB9, PSME2, PTGDS, SERPINA3 |  
        | Cell    Morphology | 14 | 14 | APOE, ARHGEF2, C4BPB, CSE1L, EIF3A, FKBP4, HIST1H2BB, LDHB, PARK7, PLTP, RALY, TMSB10/TMSB4X, UCHL1, USP5 |  |